DPS Group Promotes Andy Wilkinson to Director of Aseptic Fill Finish

·3 min read

KANSAS CITY, MO / ACCESSWIRE / August 10, 2022 / DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, today announced it has promoted Andy Wilkinson to Director of Aseptic Fill Finish. Reporting to Werner Greyling, President of U.S. Project Operations, Andy will serve as a top-level technical expert on drug product technology and work on multiple projects and programs to support clients in the fill/finish and aseptic processing design space including feasibility, conceptual, and early BOD project phases. While Andy will be based in Kansas City, he will support all U.S. project operations in current DPS offices across the country and future West Coast locations.

DPS Group Global, Wednesday, August 10, 2022, Press release picture
DPS Group Global, Wednesday, August 10, 2022, Press release picture

"The promotion of Andy is a strategic move to add more subject matter experts to our leadership team, allowing us to better serve our clients and to develop our professional staff," said Werner. "DPS remains steadfast in its commitment to stay ahead of the curve related to new technologies and design processes."

With more than 30 years of experience leading projects in the pharmaceutical industry, Andy is the Aseptic Fill Finish subject matter expert for DPS. He is a recognized leader in aseptic processing design, aseptic filling, equipment/process design, installation, qualification, operation, and remediation. Andy uses his operational and technical experience to develop and implement solutions to achieve excellent client results. His blend of owner-side operations and consulting experience allow him to bring a unique perspective and understanding of clients' needs and market factors to each project. His depth of knowledge spans multiple sectors including human pharma, animal health, 503B compounding pharmacies, generic and branded products and small-scale start-ups.

Andy received a Bachelor of Arts in Interdisciplinary Studies / Biology from University of Missouri at Columbia. He is a member of the Parenteral Drug Association (PDA).

Serving high-tech industries around the world, DPS Group delivers full-service engineering across a range of disciplines, including project management, procurement, design, construction management, health and safety management, commissioning, qualification, and validation (CQV), and facility start-up.

About DPS Group

DPS Group is a global engineering, consulting and project management company, serving high-tech industries around the world. DPS delivers services for clients across the complete engineering and construction value chain including feasibility studies, concepts, consulting, architecture, engineering, procurement, construction management, commissioning, qualification, and validation as well as client-side technical services.

DPS applies its extensive process engineering expertise built over 47 years, as well as significant Lean construction experience to assist clients in high-end process sectors such as pharmaceuticals, biotech, and semiconductors to deliver manufacturing facilities speedily, safely, and cost effectively. What sets the firm apart is the partnerships it builds with clients through a fundamental understanding of their businesses and its own agility, flexibility, original thinking, and high-caliber people.

DPS has grown substantially in recent years and now employs more than 2,500 people in 18 offices and on client sites in Ireland, U.K., Netherlands, Belgium, Sweden, Switzerland, Israel, Singapore, Saudi Arabia, and the United States. For more information, visit www.dpsgroupglobal.com.

Media Contact:

Susan Shelby, FSMPS, CPSM
Rhino PR


View source version on accesswire.com: